IRADIMED CORP — Director's Dealing 2022

Dec 7, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2022-12-05

Reporting Person: VUOTO ANTHONY (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-05	Common Stock	S	1000	$28.5474	Disposed	14121	Direct

Footnotes

F1: This transaction was executed in a single trade at $28.5474.